Advertisement
Advertisement
CLNN
Clene Inc. Common Stock
4.32
USDSponsored
-0.05
-1.14%
Aug 21, 15:59 UTC -4
Closed
After-Market
4.35
+0.03
+0.69%
CLNN Earnings Reports
Positive Surprise Ratio
CLNN beat 12 of 22 last estimates.
55%
Next Report
Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
$87.72K
/-$0.38
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
+484.80%
/-55.29%
Clene Inc. Common Stock earnings per share and revenue
On Aug 17, 2026, CLNN reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -0.37 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 74.97 thousand, with a --% difference.
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.38 USD, with revenue projected to reach 87.72 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Alvotech Ordinary Shares
Report Date
Aug 19, 2026 For Q2 26
Estimate
-$0.02
Actual
-$0.11
Surprise
-300.00%
CorMedix Inc.
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.24
Actual
$0.28
Surprise
+19.44%
Prenetics Global Limited Class A Ordinary Share
Report Date
Aug 18, 2026 For Q2 26
Estimate
-$0.71
Actual
-$0.53
Surprise
+26.30%
Fate Therapeutics, Inc.
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.27
Actual
-$0.25
Surprise
+8.49%
TuHURA Biosciences, Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+5.34%
Outlook Therapeutics, Inc. Common Stock
Report Date
Aug 14, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.09
Surprise
+5.46%
MiNK Therapeutics, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.61
Actual
-$0.62
Surprise
-1.31%
Lantern Pharma Inc. Common Stock
Report Date
Aug 14, 2026 For Q2 26
Estimate
-$0.38
Actual
-$0.28
Surprise
+27.76%
Kyntra Bio, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$3.24
Actual
-$4.68
Surprise
-44.15%
Beyond Air, Inc. Common Stock
Report Date
Aug 13, 2026 For Q1 27
Estimate
-$11.01
Actual
-$11.00
Surprise
+0.15%
FAQ
What were Clene Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Clene Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Clene Inc. Common Stock's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Clene Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 11, 2026.
What are the forecasts for Clene Inc. Common Stock's next earnings report?
Based on 5
analysts, Clene Inc. Common Stock is expected to report EPS of -$0.38 and revenue of $87.72K for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement